Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Fibrous Tissue

Explore clinical trials studying Neoplasms, Fibrous Tissue. Study availability and eligibility vary by location and protocol.

342 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Fibrous Tissue trial results

Active, Not Recruiting

National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)

NCT02867033

Conditions
Aggressive Fibromatosis, Desmoid Tumors, Fibroma, +5 more
Locations
  • Institut de Cancérologie de l'Ouest - Paul Papin Angers, France
  • CHU Angers Angers, France
  • CHU de Besançon Besançon, France
  • Hôpital des Enfants Bordeaux, France
View all 39 locations
View Trial Details
Active, Not Recruiting

A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

NCT03899792

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Breast Diseases, +52 more
Locations
  • Childrens Hospital of Los Angeles Los Angeles, California, United States
  • The Children's Hospital for Cancer and Blood Disorders Aurora, Colorado, United States
  • Nemours Children's Health Orlando, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00565851

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, +51 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 709 locations
View Trial Details
Active, Not Recruiting

A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

NCT03611868

Conditions
Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +33 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Highlands Oncology Rogers, Arkansas, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
  • Sarcoma Oncology Research Center Santa Monica, California, United States
View all 21 locations
View Trial Details

Related conditions